Center for Stem Cell Engineering, Department of Basic Research Laboratories, Texas Heart Institute at St. Luke's Episcopal Hospital, 6770 Bertner Avenue, MC 2-255, Houston, TX 77030, USA.
In Vitro Fertilization Center, Affiliated Hospital of Hainan Medical University, 31 Long-Hua Road, Haikou, Hainan 570102, People's Republic of China.
J Mol Cell Cardiol. 2015 Jan;78:154-64. doi: 10.1016/j.yjmcc.2014.08.003. Epub 2014 Aug 12.
Cardiomyopathy presents a major health issue and is a leading cause of heart failure. Although a subset of familial cardiomyopathy is associated with genetic mutations, over 50% of cardiomyopathy is defined as idiopathic, the mechanisms underlying which are under intensive investigation. SUMO conjugation is a dynamic posttranslational modification that can be readily reversed by the activity of sentrin-specific proteases (SENPs). However, whether SENPs are implicated in heart disease pathophysiology remains unexplored. We observed a significant increase in the level of SENP5, a SUMO isopeptidase, in human idiopathic failing hearts. To reveal whether it plays a role in the pathogenesis of cardiac muscle disorders, we used a gain-of-function approach to overexpress SENP5 in murine cardiomyocytes (SENP5 transgenic, SENP5-Tg). Overexpression of SENP5 led to cardiac dysfunction, accompanied by decreased cardiomyocyte proliferation and elevated apoptosis. The increase in apoptosis preceded other detectable pathological changes, suggesting its causal link to cardiomyopathy. Further examination of SENP5-Tg hearts unveiled a decrease in SUMO attachment to dynamin related protein (Drp1), a factor critical for mitochondrial fission. Correspondingly, the mitochondria of SENP5-Tg hearts at an early developmental stage were significantly larger compared with those in the control hearts, suggesting that desumoylation of Drp1 at least partially accounts for the cardiac phenotypes observed in the SENP5-Tg mice. Finally, overexpression of Bcl2 in SENP5-Tg hearts improved cardiac function of SENP5-Tg mice, further supporting the notion that SENP5 mainly targets mitochondrial function in vivo. Our findings demonstrate an important role of the desumoylation enzyme SENP5 in the development of cardiac muscle disorders, and point to the SUMO conjugation pathway as a potential target in the prevention/treatment of cardiomyopathy. This article is part of a Special Issue entitled "Mitochondria: From Basic Mitochondrial Biology to Cardiovascular Disease".
心肌病是一个主要的健康问题,也是心力衰竭的主要原因。尽管一部分家族性心肌病与基因突变有关,但超过 50%的心肌病被定义为特发性,其潜在机制正在深入研究中。SUMO 连接是一种动态的翻译后修饰,可以通过 SENP 的活性很容易地逆转。然而,SENP 是否与心脏病的病理生理学有关仍然未知。我们观察到在人类特发性衰竭心脏中,SUMO 异肽酶 SENP5 的水平显著增加。为了揭示它是否在心肌疾病发病机制中起作用,我们使用了过表达 SENP5 的功能获得方法在鼠心肌细胞(SENP5 转基因,SENP5-Tg)中。SENP5 的过表达导致心脏功能障碍,伴随着心肌细胞增殖减少和凋亡增加。凋亡的增加先于其他可检测到的病理变化,表明其与心肌病有因果关系。对 SENP5-Tg 心脏的进一步检查显示,SUMO 与动力相关蛋白(Drp1)的结合减少,而 Drp1 是线粒体分裂的关键因素。相应地,SENP5-Tg 心脏在早期发育阶段的线粒体明显大于对照心脏,表明 Drp1 的去 SUMO 化至少部分解释了 SENP5-Tg 小鼠中观察到的心脏表型。最后,在 SENP5-Tg 心脏中过表达 Bcl2 改善了 SENP5-Tg 心脏的功能,进一步支持了 SENP5 主要在体内靶向线粒体功能的观点。我们的研究结果表明,去 SUMO 化酶 SENP5 在心肌疾病的发展中起着重要作用,并指出 SUMO 连接途径可能是预防/治疗心肌病的潜在靶点。本文是特刊题为“线粒体:从基础线粒体生物学到心血管疾病”的一部分。